IgG Antibodies to GlcNAcβ and Asialo-GM2 (GA2) Glycans as Potential Markers of Liver Damage in Chronic Hepatitis C and the Efficacy of Antiviral Treatment

Table 5

Binary logistic regression analysis of the Ab level in the discrimination of patients with fibrosis and predicting treatment response.

Abs (variables)	Cut-off	Characteristics	Odds ratio (Exp B)	95% CI
Anti-GlcNAcβ	0.334	F0, F1–4	4.11	1.49–23.51	0.024
Anti-GA2	0.232	SVR, non-SVR	4.26	1.12–16.15	0.033